Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.2340
+0.0410 (21.24%)
May 27, 2026, 5:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 12.89 million as of May 27, 2026. Its market cap has decreased by -24.46% in one year.
Market Cap
12.89M
Enterprise Value
14.68M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 12.89M, a decrease of -86.70%. That is a compound annual growth rate of -28.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 12.89M | 28.67% |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.28T |
| Genmab | 105.81B |
| Coloplast | 90.88B |
| ALK-Abelló | 58.27B |
| Gubra | 5.55B |
| BioPorto | 616.41M |
| ViroGates | 101.17M |
| Pharma Equity Group | 96.73M |